LAVA Therapeutics N.V. revenue breakdown overview

LAVA Therapeutics N.V. revenue for the last year amounted to 6.77 M USD, the most of which — 7.32 M USD — came from its highest performing source at the moment, Novel Bispecific Antibodies, the year earlier bringing 20.38 M USD. The greatest contribution to the revenue figure was made by Netherlands — last year it brought LAVA Therapeutics N.V. 7.32 M USD, and the year before that — 20.38 M USD.